Ikarian Capital’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Hold |
0
| – | – | – | 131 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 107 |
|
2024
Q1 | – | Sell |
-555,572
| Closed | -$1.56M | – | 91 |
|
2023
Q4 | $1.56M | Hold |
555,572
| – | – | 0.15% | 43 |
|
2023
Q3 | $1.59M | Buy |
555,572
+10,469
| +2% | +$30K | 0.19% | 35 |
|
2023
Q2 | $2.75M | Buy |
+545,103
| New | +$2.75M | 0.44% | 27 |
|
2022
Q2 | – | Sell |
-159,390
| Closed | -$441K | – | 111 |
|
2022
Q1 | $441K | Buy |
159,390
+8,906
| +6% | +$24.6K | 0.06% | 101 |
|
2021
Q4 | $801K | Hold |
150,484
| – | – | 0.12% | 79 |
|
2021
Q3 | $1.27M | Sell |
150,484
-3,457
| -2% | -$29.2K | 0.09% | 87 |
|
2021
Q2 | $1.88M | Hold |
153,941
| – | – | 0.15% | 89 |
|
2021
Q1 | $3.74M | Sell |
153,941
-140,000
| -48% | -$3.4M | 0.13% | 61 |
|
2020
Q4 | $9.42M | Sell |
293,941
-65,000
| -18% | -$2.08M | 0.42% | 16 |
|
2020
Q3 | $10.9M | Buy |
358,941
+181,397
| +102% | +$5.48M | 0.79% | 9 |
|
2020
Q2 | $7.49M | Buy |
+177,544
| New | +$7.49M | 0.6% | 17 |
|